Reagents, Tumor Markers

Known as: markers tumor, tumor markers 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2018
05010019762018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BACKGROUND Circulating tumor cells (CTCs) are a prognostic marker in metastatic breast cancer, but comparisons with serum tumor… (More)
Is this relevant?
2008
2008
BACKGROUND This report presents updated National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Early diagnosis of recurrent breast cancer is crucial to selection of the most appropriate therapy. The current study… (More)
Is this relevant?
Highly Cited
2004
2004
2004
Using global gene expression analyses, multiple novel tumor markers overexpressed in infiltrating ductal adenocarcinomas of the… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE Trastuzumab-based therapy improves survival for women with human epidermal growth factor receptor 2 (HER2)-positive… (More)
Is this relevant?
2000
2000
PURPOSE To evaluate the dose, toxicity, and efficacy of paclitaxel in combination with ifosfamide and cisplatin as salvage… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND The prognoses of patients with squamous cell carcinoma of the ovary are quite poor. However, preoperative diagnosis is… (More)
Is this relevant?
1998
1998
BACKGROUND AND PURPOSE Almost 10% of breast and ovarian cancers are familial, and the majority are linked to BRCA1 and BRCA2… (More)
Is this relevant?
1993
1993
BACKGROUND Recent studies have shown that multiple cytokines are secreted by ovarian epithelial cancer cells. Previous studies… (More)
Is this relevant?